Millennium Management
CAMP icon

Millennium Management’s CAMP4 Therapeutics CAMP Stock Holding History

Millennium Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Buy
85,918
+75,816
+751% +$360K ﹤0.01% 4907
2025
Q4 		$61.9K Sell
10,102
-84,969
-89% -$361K ﹤0.01% 5709
2025
Q3 		$285K Sell
95,071
-37,965
-29% -$70.3K ﹤0.01% 5360
2025
Q2 		$193K Buy
+133,036
New +$265K ﹤0.01% 5378

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's CAMP Position: Q1 2026 in Review

Millennium Management increased its CAMP4 Therapeutics (CAMP) stake by 751% in Q1 2026, buying an estimated $360K and bringing the position to 85,918 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #4907.

Millennium Management first reported a position in CAMP in Q2 2025 and has held it in 4 quarters since. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Millennium Management held 85,918 shares of CAMP4 Therapeutics worth $379K as of Q1 2026.
  • Millennium Management bought 75,816 CAMP4 Therapeutics shares in Q1 2026, an estimated $360K.
  • CAMP4 Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4907 holding.
  • Millennium Management first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.